Purified capsular polysaccharide of neisseria meningitidis serogroup a as immune potentiator for antibody production

Current Microbiology

Volumn 60, Issue 2, 2010, Pages 79-84

  Menéndez, Tamara ^a   Carmenate, Tania ^a   Cruz Leal, Yoelys ^a   Coizeau, Edelgis ^a   Caballero, Evelyn ^a   Bello, Daniel ^a   Guirola, María ^a   Álvarez, Anabel ^a   Guillén, Gerardo ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSULAR POLYSACCHARIDE A; POLYSACCHARIDE VACCINE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG SAFETY; FEMALE; IMMUNIZATION; MENINGOCOCCOSIS; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL CAPSULES; BLOOD BACTERICIDAL ACTIVITY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; MICE; MICE, INBRED BALB C; NEISSERIA MENINGITIDIS, SEROGROUP A; POLYSACCHARIDES, BACTERIAL; RANDOM ALLOCATION;

MUS; NEISSERIA MENINGITIDIS SEROGROUP A;

EID: 76949108598     PISSN: 03438651     EISSN: 14320991     Source Type: Journal    
DOI: 10.1007/s00284-009-9505-9     Document Type: Article

References (31)

1. BJ Appelmelk I van Die SJ van Vliet CM Vandenbroucke-Grauls TB Geijtenbeek Y van Kooyk 2003 Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells J Immunol 170 1635 1639 1:CAS:528: DC%2BD3sXht12itrs%3D 12574325
2. A Avrameas D McIlroy A Hosmalin B Autran P Debre M Monsigny AC Roche P Midoux 1996 Expression of a mannose/fucose membrane lectin on human dendritic cells Eur J Immunol 26 394 400 10.1002/eji.1830260219 1:CAS:528: DyaK28XhtFGjsbw%3D 8617309 (Pubitemid 26060247)
3. AK Bhattacharjee HJ Jennings CP Kenny A Martin IC Smith 1975 Structural determination of the sialic acid polysaccharide antigens of Neisseria meningitidis serogroups B and C with carbon 13 nuclear magnetic resonance J Biol Chem 250 1926 1932 1:CAS:528:DyaE2MXhsFemtb4%3D 163259
4. R Borrow N Andrews D Goldblatt E Miller 2001 Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection Infect Immun 69 1568 1573 10.1128/IAI.69.3.1568-1573.2001 1:CAS:528:DC%2BD3MXitFGrtbw%3D 11179328 (Pubitemid 32187610)
5. R Borrow D Goldblatt N Andrews P Richmond J Southern E Miller 2001 Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children J Infect Dis 184 377 380 10.1086/322024 1:CAS:528:DC%2BD3MXlvFOhu7g%3D 11443568 (Pubitemid 32662189)
6. S Burgdorf A Kautz V Bohnert PA Knolle C Kurts 2007 Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation Science 316 612 616 10.1126/science.1137971 1:CAS:528:DC%2BD2sXksFeksbk%3D 17463291 (Pubitemid 46683149)
7. T Carmenate L Canaan A Alvarez M Delgado S Gonzalez T Menendez L Rodes G Guillen 2004 Effect of conjugation methodology on the immunogenicity and protective efficacy of meningococcal group C polysaccharide-P64k protein conjugates FEMS Immunol Med Microbiol 40 193 199 10.1016/S0928-8244(03)00346-8 1:CAS:528:DC%2BD2cXisVGgtrk%3D 15039094 (Pubitemid 38368182)
8. T Carmenate M Guirola A Alvarez L Canaan S Gonzalez E Caballero T Menendez G Guillen 2005 Memory immune response generated in Cercopithecus aethiops against meningococcal polysaccharide serogroup C conjugate vaccine FEMS Immunol Med Microbiol 43 133 140 10.1016/j.femsim.2004.07.003 1:CAS:528:DC%2BD2MXosVCrsg%3D%3D 15681142 (Pubitemid 40170281)
9. JP Chippaux A Garba C Ethevenaux G Campagne F de Chabalier S Djibo P Nicolas H Ali M Charrondiere R Ryall M Bybel A Schuchat 2004 Immunogenicity, safety, and memory of different schedules of Neisseria meningitidis A/C-diphtheria toxoid conjugate vaccine in infants in Niger Vaccine 22 3303 3311 10.1016/j.vaccine.2004.02.028 1:CAS:528:DC%2BD2cXmsl2jsrw%3D 15308353 (Pubitemid 39078746)
10. L Danzig 2004 Meningococcal vaccines Pediatr Infect Dis J 23 S285 S292 10.1097/01.inf.0000115641.34032.de 15597071
11. DeFranco AL, Locksley RM, Robertson M (2007) Immunity: the immune response in infectious and inflammatory disease. New Science Press Ltd, London, UK
12. A Engering TB Geijtenbeek SJ van Vliet M Wijers E van Liempt N Demaurex A Lanzavecchia J Fransen CG Figdor V Piguet Y van Kooyk 2002 The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells J Immunol 168 2118 2126 1:CAS:528:DC%2BD38XhvVehurc%3D 11859097
13. CG Figdor Y van Kooyk GJ Adema 2002 C-type lectin receptors on dendritic cells and Langerhans cells Nat Rev Immunol 2 77 84 10.1038/nri723 1:CAS:528:DC%2BD38XitFSnu78%3D 11910898 (Pubitemid 37323231)
14. LL Gheesling GM Carlone LB Pais PF Holder SE Maslanka BD Plikaytis M Achtman P Densen CE Frasch Kayhty Hetal 1994 Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay J Clin Microbiol 32 1475 1482 1:CAS:528:DyaK2cXksFGgu7w%3D 8077392
15. DM Granoff RK Gupta RB Belshe EL Anderson 1998 Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination J Infect Dis 178 870 874 10.1086/515346 1:CAS:528:DyaK1cXlvVyktrw%3D 9728562
16. M Guirola T Carmenate T Menendez A Alvarez S Gonzalez G Guillen 2006 Comparison of three ELISA protocols to measure antibody responses elicited against serogroup C meningococcal polysaccharide in mouse, monkey and human sera J Microbiol Methods 65 135 143 10.1016/j.mimet.2005.06.015 1:CAS:528: DC%2BD28XisF2js7c%3D 16122825
17. H Jokhdar R Borrow A Sultan M Adi C Riley E Fuller D Baxter 2004 Immunologic hyporesponsiveness to serogroup C but not serogroup A following repeated meningococcal A/C polysaccharide vaccination in Saudi Arabia Clin Diagn Lab Immunol 11 83 88 1:CAS:528:DC%2BD2cXht1egsbY%3D 14715549
18. J MacLennan S Obaro J Deeks D Lake C Elie G Carlone ER Moxon B Greenwood 2001 Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy J Infect Dis 183 97 104 10.1086/317667 1:CAS:528:DC%2BD3MXot1Gmtw%3D%3D 11087205 (Pubitemid 32043046)
19. SE Maslanka LL Gheesling DE Libutti KB Donaldson HS Harakeh JK Dykes FF Arhin SJ Devi CE Frasch JC Huang P Kriz-Kuzemenska RD Lemmon M Lorange CC Peeters S Quataert JY Tai GM Carlone 1997 Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group Clin Diagn Lab Immunol 4 156 167 1:STN:280:DyaK2s3itVCrtQ%3D%3D 9067649
20. A Pashine NM Valiante JB Ulmer 2005 Targeting the innate immune response with improved vaccine adjuvants Nat Med 11 S63 S68 10.1038/nm1210 1:CAS:528:DC%2BD2MXjsFWmsrg%3D 15812492 (Pubitemid 40562305)
21. MS Peppler CE Frasch 1982 Protection against group B Neisseria meningitidis disease effect of serogroup B polysaccharide and polymyxin B on immunogenicity of serotype protein preparations Infect Immun 37 264 270 1:STN:280:DyaL383msVagtw%3D%3D 6809628
22. A Perez F Dickinson Z Cinza A Ruiz T Serrano J Sosa S Gonzalez Y Gutierrez C Nazabal O Gutierrez D Guzman M Diaz M Delgado E Caballero G Sardinas A Alvarez A Martin G Guillen R Silva 2001 Safety and preliminary immunogenicity of the recombinant outer membrane protein P64k of Neisseria meningitidis in human volunteers Biotechnol Appl Biochem 34 121 125 10.1042/BA20010029 1:CAS:528:DC%2BD3MXotFWqtbs%3D 11592918 (Pubitemid 32977943)
23. AE Perez FO Dickinson F Banderas T Serrano R Llanes D Guzman P Diaz A Alvarez M Guirola E Caballero L Canaan-Haden G Guillen 2006 Safety and preliminary immunogenicity of MenC/P64k, a meningococcal serogroup C conjugate vaccine with a new recombinant carrier FEMS Immunol Med Microbiol 46 386 392 10.1111/j.1574-695X.2006.00047.x 1:CAS:528:DC%2BD28XktVCksb4%3D 16553812
24. E Rosenqvist EA Hoiby G Bjune A Aase A Halstensen AK Lehmann J Paulssen J Holst TE Michaelsen H Nokleby LO Froholm O Closs 1998 Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine Dev Biol Stand 92 323 333 1:CAS:528:DyaK1cXjsVShtro%3D 9554288
25. I Seppala J Pelkonen O Makela 1985 Isotypes of antibodies induced by plain dextran or a dextran-protein conjugate Eur J Immunol 15 827 833 10.1002/eji.1830150816 1:CAS:528:DyaL2MXlt1Wgurc%3D 2411572 (Pubitemid 16242850)
26. GV Sierra HC Campa NM Varcacel IL Garcia PL Izquierdo PF Sotolongo GV Casanueva CO Rico CR Rodriguez MH Terry 1991 Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba NIPH Ann 14 195 207 1:STN:280:DyaK383ltlSrtg%3D%3D 1812432
27. R Silva T Menendez LM Alonso E Iglesias A Musacchio MJ Leal A Alvarez E Coizeau A Martin L Herrera G Guillen 1999 Characterisation of the lpdA gene from Neisseria meningitidis by polymerase chain reaction, restriction fragment length polymorphism and sequencing FEMS Microbiol Lett 174 191 199 10.1111/j.1574-6968.1999.tb13568.x 1:CAS:528:DyaK1MXivFyqt70%3D 10234839
28. J Southern S Deane L Ashton R Borrow D Goldblatt N Andrews P Balmer R Morris JS Kroll E Miller 2004 Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults Clin Diagn Lab Immunol 11 1100 1104 1:CAS:528:DC%2BD2cXhtFShsrrK 15539513
29. J Suker IM Feavers MJ Corbel C Jones B Bolgiano 2004 Control and lot release of meningococcal group C conjugate vaccines Expert Rev Vaccines 3 533 540 10.1586/14760584.3.5.533 15485333 (Pubitemid 39440829)
30. I Valdes L Hermida J Martin T Menendez L Gil L Lazo J Castro O Niebla C Lopez L Bernardo J Sanchez Y Romero R Martinez MG Guzman G Guillen 2009 Immunological evaluation in nonhuman primates of formulations based on the chimeric protein P64k-domain III of dengue 2 and two components of Neisseria meningitidis Vaccine 27 995 1001 10.1016/j.vaccine.2008.11.106 1:CAS:528:DC%2BD1MXhtlSksbY%3D 19100804
31. CG Vinuesa C de Lucas MC Cook 2001 Clinical implications of the specialised B cell response to polysaccharide encapsulated pathogens Postgrad Med J 77 562 569 10.1136/pmj.77.911.562 1:CAS:528:DC%2BD3MXntFGqt78%3D 11524513 (Pubitemid 32831755)